JPH10508035A - βシート模倣物およびプロテアーゼインヒビターとしてのその使用 - Google Patents

βシート模倣物およびプロテアーゼインヒビターとしてのその使用

Info

Publication number
JPH10508035A
JPH10508035A JP8529594A JP52959496A JPH10508035A JP H10508035 A JPH10508035 A JP H10508035A JP 8529594 A JP8529594 A JP 8529594A JP 52959496 A JP52959496 A JP 52959496A JP H10508035 A JPH10508035 A JP H10508035A
Authority
JP
Japan
Prior art keywords
sheet
following structure
beta sheet
mimic
integer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP8529594A
Other languages
English (en)
Japanese (ja)
Inventor
マイケル カーン，
Original Assignee
モレキュメティックス リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by モレキュメティックス リミテッド filed Critical モレキュメティックス リミテッド
Priority claimed from PCT/US1996/004115 external-priority patent/WO1996030396A1/en
Publication of JPH10508035A publication Critical patent/JPH10508035A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Materials For Medical Uses (AREA)
  • Paper (AREA)
JP8529594A 1995-03-24 1996-03-25 βシート模倣物およびプロテアーゼインヒビターとしてのその使用 Withdrawn JPH10508035A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US41051895A 1995-03-24 1995-03-24
US54900695A 1995-10-27 1995-10-27
US08/549,006 1995-10-27
US08/410,518 1995-10-27
PCT/US1996/004115 WO1996030396A1 (en) 1995-03-24 1996-03-25 β-SHEET MIMETICS AND USE THEREOF AS PROTEASE INHIBITORS

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2000079170A Division JP2000319295A (ja) 1995-03-24 2000-03-21 βシート模倣物およびプロテアーゼインヒビターとしてのその使用

Publications (1)

Publication Number Publication Date
JPH10508035A true JPH10508035A (ja) 1998-08-04

Family

ID=27021026

Family Applications (4)

Application Number Title Priority Date Filing Date
JP8529594A Withdrawn JPH10508035A (ja) 1995-03-24 1996-03-25 βシート模倣物およびプロテアーゼインヒビターとしてのその使用
JP8529567A Pending JPH10508034A (ja) 1995-03-24 1996-03-25 βシート模倣物および生物学的に活性なペプチドまたはタンパク質のインヒビターとしてのその使用
JP2000079170A Withdrawn JP2000319295A (ja) 1995-03-24 2000-03-21 βシート模倣物およびプロテアーゼインヒビターとしてのその使用
JP2004017703A Expired - Lifetime JP4152900B2 (ja) 1995-03-24 2004-01-26 βシート模倣物およびプロテアーゼインヒビターとしてのその使用

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP8529567A Pending JPH10508034A (ja) 1995-03-24 1996-03-25 βシート模倣物および生物学的に活性なペプチドまたはタンパク質のインヒビターとしてのその使用
JP2000079170A Withdrawn JP2000319295A (ja) 1995-03-24 2000-03-21 βシート模倣物およびプロテアーゼインヒビターとしてのその使用
JP2004017703A Expired - Lifetime JP4152900B2 (ja) 1995-03-24 2004-01-26 βシート模倣物およびプロテアーゼインヒビターとしてのその使用

Country Status (8)

Country Link
EP (2) EP0815123B1 (enExample)
JP (4) JPH10508035A (enExample)
AT (1) ATE206433T1 (enExample)
AU (2) AU713530B2 (enExample)
CA (2) CA2215695C (enExample)
DE (1) DE69615671T2 (enExample)
ES (1) ES2161354T3 (enExample)
WO (1) WO1996030035A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840835A (en) * 1995-10-30 1998-11-24 Merck & Co., Inc. Inhibitors of peptide binding to MHC class II proteins
US5817757A (en) * 1995-10-30 1998-10-06 Merck & Co., Inc. Inhibitors of peptide binding to MHO class II proteins
AU7604196A (en) * 1995-10-30 1997-05-22 Merck & Co., Inc. Novel inhibitors of peptide binding to mhc class ii proteins
US5719296A (en) * 1995-10-30 1998-02-17 Merck & Co., Inc. Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins
GB9702377D0 (en) * 1996-02-23 1997-03-26 Zeneca Ltd Peptide derivatives
NZ332347A (en) 1996-06-07 2000-05-26 Zeneca Ltd Peptide derivatives containing a hydrophobic group, L-amino acid residues and modified L-amino acid residues
NZ332740A (en) 1996-06-18 2000-05-26 Warner Lambert Co heterocyclically substituted carbamate or sulphonamide derivatives
ES2262184T3 (es) * 1996-08-05 2006-11-16 Myriad Genetics, Inc. Utilizacion de mimeticos de hojas beta como inhibidores de proteasa y de kinasa o como inhibidores de factores de transcripcion.
EP1661566A3 (en) * 1996-08-05 2008-04-16 Myriad Genetics, Inc. Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
GB9621836D0 (en) 1996-10-19 1996-12-11 Zeneca Ltd Peptide compounds
GB9624562D0 (en) * 1996-11-27 1997-01-15 Zeneca Ltd Peptide derivatives
GB9625865D0 (en) * 1996-12-12 1997-01-29 Zeneca Ltd Peptides
ATE230414T1 (de) * 1998-02-12 2003-01-15 Molecumetics Ltd Mimetika von beta-faltblatt und verfahren zur verwendung davon
US6323219B1 (en) 1998-04-02 2001-11-27 Ortho-Mcneil Pharmaceutical, Inc. Methods for treating immunomediated inflammatory disorders
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
HUP0201295A3 (en) 1999-01-27 2002-10-28 Ortho Mcneil Pharm Inc Peptidyl heterocyclic ketones useful as tryptase inhibitors
US7309688B2 (en) 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
WO2001064678A2 (en) * 2000-02-29 2001-09-07 Bristol-Myers Squibb Pharma Company Inhibitors of hepatitis c virus ns3 protease
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
US20120296067A1 (en) 2010-02-03 2012-11-22 Prism BioLab Co., Ltd. Compound capable of binding to naturally occurring denatured protein, and method for screening for the compound
ES2819218T3 (es) 2014-10-06 2021-04-15 Cortexyme Inc Inhibidores de lisina gingipaína
WO2017083433A1 (en) 2015-11-09 2017-05-18 Cortexyme, Inc. Inhibitors of arginine gingipain
KR102780603B1 (ko) 2016-09-16 2025-03-12 라이트하우스 파마슈티컬스, 인코포레이티드 리신 진지파인의 케톤 억제제

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA896851B (en) * 1988-09-14 1990-06-27 Hoffmann La Roche Use of ace-inhibitors

Also Published As

Publication number Publication date
EP0815123A1 (en) 1998-01-07
EP0815123B1 (en) 2001-10-04
JP2004131511A (ja) 2004-04-30
CA2215695C (en) 2003-09-16
WO1996030035A1 (en) 1996-10-03
AU5371496A (en) 1996-10-16
AU712581B2 (en) 1999-11-11
CA2215695A1 (en) 1996-10-03
JP2000319295A (ja) 2000-11-21
ATE206433T1 (de) 2001-10-15
ES2161354T3 (es) 2001-12-01
CA2215720A1 (en) 1996-10-03
JP4152900B2 (ja) 2008-09-17
DE69615671D1 (de) 2001-11-08
JPH10508034A (ja) 1998-08-04
DE69615671T2 (de) 2002-08-08
EP0817642A1 (en) 1998-01-14
AU713530B2 (en) 1999-12-02
AU5372996A (en) 1996-10-16

Similar Documents

Publication Publication Date Title
EP0815123B1 (en) Beta-sheet mimetics and use thereof as protease inhibitors
EP0699074B1 (en) Thrombin inhibitors
EP0772590B1 (en) Thrombin inhibitors
AU732174B2 (en) Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
WO1996030396A1 (en) β-SHEET MIMETICS AND USE THEREOF AS PROTEASE INHIBITORS
US6245764B1 (en) β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
US6586426B1 (en) β-sheet mimetics and use thereof as protease inhibitors
AU748887B2 (en) Beta-sheet mimetics and methods relating to the use thereof
RU2175327C2 (ru) Производные имидазо[1,5-а]пиридина как ингибиторы серинпротеаз и фармацевтическая композиция
US6699869B1 (en) β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
AU733205B2 (en) Beta-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
US20030191109A1 (en) Beta-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
CN1189165A (zh) 咪唑并[1,5α]吡啶衍生的丝氨酸蛋白酶抑制剂
EP1661566A2 (en) Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors

Legal Events

Date Code Title Description
A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20050708

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20050713

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051007

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20061109